Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: Effects on survival and quality of life

Journal of Clinical Oncology

Volumn 17, Issue 10, 1999, Pages 3188-3194

  Cullen, M H ^a   Billingham, L J ^a   Woodroffe, C M ^a   Chetiyawardana, A D ^a   Gower, N H ^a   Joshi, R ^a   Ferry, D R ^a   Rudd, R M ^a   Spiro, S G ^a   Cook, J E ^a   Trask, C ^a   Bessell, E ^a   Connolly, C K ^a   Tobias, J ^a   Souhami, R L ^a  

^a MANOR HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; IFOSFAMIDE; MITOMYCIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE;

EID: 0032887573     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1999.17.10.3188     Document Type: Article

References (30)

1. Mattson K, Holsti LR, Holsti P, et al: Inoperable non-small cell lung cancer: Radiation with or without chemotherapy. Eur J Cancer 24:477-482, 1988
2. Morton RF, James R, Jett JR, et al: Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. Ann Intern Med 115:681-686, 1991
3. Dillman RO, Herndon J, Seagren SL, et al: Improved survival in stage III non-small cell lung cancer: Seven year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial. J Natl Cancer Inst 88:1210-1215, 1996
4. Rapp E, Pater JL, Willan A, et al: Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer: Report of a Canadian multicentre randomized trial. J Clin Oncol 6:633-641, 1988
5. Johnson DH: Chemotherapy for metastatic non-small cell lung cancer: Can that dog hunt? J Natl Cancer Inst 85:766-767, 1993
6. Raby B, Pater J, Mackillop WJ: Does knowledge guide practice? Another look at the management of non-small-cell lung cancer. J Clin Oncol 13:1904-1911, 1995
7. Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised trials. Br Med J 311:899-909, 1995
8. Le Lorier J, Grégoire G, Benhaddad A, et al: Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 337:536-542, 1997
9. Cullen MH, Joshi R, Chetiyawardana AD, et al: Mitomycin, ifosfamide and cisplatin in non-small cell lung cancer: Treatment good enough to compare. Br J Cancer 58:359-361, 1988
10. Eagan RT, Fleming TR, Schoonover V: Evaluation of response criteria in advanced lung cancer. Cancer 44:1125-1128, 1979
11. Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376, 1993
12. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. Am Stat Assoc J 53:457-481, 1958
13. Cox DR: Regression models and life tables (with discussion). J R Stat Soc B 34:187-220, 1972
14. Minna JD, Higgins GA, Glatstein EJ: Cancer of the lung, in DeVita VT, Hellman S, Rosenberg SA (eds): Principles and Practice of Oncology. Philadelphia, PA, JB Lippincott Co, 1982, pp 396-474
15. Giron CG, Ordonez A, Jalon JI, et al: Combination chemotherapy with ifosfamide, mitomycin and cisplatin in advanced non-small cell lung cancer. Cancer Treat Rep 71:851-853, 1987
16. Rosell R, Gomez-Codina J, Camps C, et al: A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.N Engl J Med 330:153-158, 1994
17. Crino L, Clerici M, Figoli F, et al: Chemotherapy of advanced non-small cell lung cancer: A comparison of three active regimens - A randomized trial of the Italian Oncology Group for Clinical Research (GOIRC). Ann Oncol 6:347-353, 1995
18. Johnson DH, Paul DM, Hande KR, et al: Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: A phase II trial. J Clin Oncol 14:2054-2060, 1996
19. Abratt RP, Bezwoda WR, Goedhals L, et al: Weekly gemcitabine with monthly cisplatin: Effective chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol 15:744-749, 1997
20. Le Chevalier T, Brisgand D, Douillard J-Y, et al: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients. J Clin Oncol 12:360-367, 1994
21. Cox JD, Komaki R, Byhardt RW: Is immediate chest radiotherapy obligatory for any or all patients with limited-stage non-small cell carcinoma of the lung? Yes. Cancer Treat Rep 67:327-331, 1983
22. Perez CA, Stanley K, Grunday G, et al: Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oatcell carcinoma of the lung: Report by the Radiation Therapy Oncology Group. Cancer 50:1091-1099, 1982
23. Le Chevalier T, Arriagada R, Quoix E, et al: Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable nonsmall cell lung carcinoma. J Natl Cancer Inst 83:417-423, 1991
24. Le Chevalier T, Arriagada R, Tarayre: Significant effect of adjuvant therapy on survival in locally advanced non-small cell lung cancer. J Natl Cancer Inst 84:58, 1992 (abstr)
25. Sause WT, Scott C, Taylor S, et al: Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer. J Natl Cancer Inst 87:198-205, 1995
26. Cartei G, Cartei F, Cantone A, et al: Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic NSCLC. J Natl Cancer Inst 85:794-800, 1993
27. Hardy JR, Noble T, Smith IE: Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer. Br J Cancer 60:764-766, 1989
28. Silvestri G, Pritchard R, Welch HG: Preferences for chemotherapy in patients with advanced non-small cell lung cancer: Descriptive study based on scripted interviews. Br Med J 317:771-775, 1998
29. Coy P, Elwood JM, Coldman AJ: Clinical indicators of prognosis in unresected lung cancer. Chest 80:453-458, 1981
30. Giron CG, Perez YF, Navarro JG, et al: Revision del tratamiento del carcinoma no microcitico de pulmon con la combinacion mitomicinaifosfamida-cisplatino (MIP). Oncologia 19:377-387, 1996